These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
698 related articles for article (PubMed ID: 28481733)
21. Expression of a gap junction protein, connexin43, in a large panel of human gliomas: new insights. Crespin S; Fromont G; Wager M; Levillain P; Cronier L; Monvoisin A; Defamie N; Mesnil M Cancer Med; 2016 Aug; 5(8):1742-52. PubMed ID: 27306693 [TBL] [Abstract][Full Text] [Related]
22. Transcriptional expression of ZICs as an independent indicator of survival in gliomas. Han Z; Jia J; Lv Y; Wang R; Cao K Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426 [TBL] [Abstract][Full Text] [Related]
23. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas. Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164 [TBL] [Abstract][Full Text] [Related]
24. Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas. Liu M; Lin Y; Zhang XC; Tan YH; Yao YL; Tan J; Zhang X; Cui YH; Liu X; Wang Y; Bian XW Lab Invest; 2017 Nov; 97(11):1354-1363. PubMed ID: 28759011 [TBL] [Abstract][Full Text] [Related]
25. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry. Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805 [TBL] [Abstract][Full Text] [Related]
26. Molecular profiles for insular low-grade gliomas with putamen involvement. Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911 [TBL] [Abstract][Full Text] [Related]
27. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade. Huang RQ; Shi DL; Huang W; Chen F; Lu YC J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095 [TBL] [Abstract][Full Text] [Related]
28. Molecular classification and survival prediction in human gliomas based on proteome analysis. Iwadate Y; Sakaida T; Hiwasa T; Nagai Y; Ishikura H; Takiguchi M; Yamaura A Cancer Res; 2004 Apr; 64(7):2496-501. PubMed ID: 15059904 [TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic value of the WEE1 kinase in gliomas. Music D; Dahlrot RH; Hermansen SK; Hjelmborg J; de Stricker K; Hansen S; Kristensen BW J Neurooncol; 2016 Apr; 127(2):381-9. PubMed ID: 26738845 [TBL] [Abstract][Full Text] [Related]
30. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas. Vachher M; Arora K; Burman A; Kumar B J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121 [TBL] [Abstract][Full Text] [Related]
31. MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma. Sun JZ; Zhang JH; Li JB; Yuan F; Tong LQ; Wang XY; Chen LL; Fan XG; Zhang YM; Ren X; Zhang C; Yu SP; Yang XJ Dis Markers; 2021; 2021():6680883. PubMed ID: 34211612 [TBL] [Abstract][Full Text] [Related]
33. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers]. Liu J; Xu K; Ma L; Wang Y Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410 [TBL] [Abstract][Full Text] [Related]
34. A miRNA signature for defining aggressive phenotype and prognosis in gliomas. Barbano R; Palumbo O; Pasculli B; Galasso M; Volinia S; D'Angelo V; Icolaro N; Coco M; Dimitri L; Graziano P; Copetti M; Valori VM; Maiello E; Carella M; Fazio VM; Parrella P PLoS One; 2014; 9(10):e108950. PubMed ID: 25279461 [TBL] [Abstract][Full Text] [Related]
35. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas. Tsai WC; Hueng DY; Nieh S; Gao HW J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434 [TBL] [Abstract][Full Text] [Related]
36. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation. Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073 [TBL] [Abstract][Full Text] [Related]
37. The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis. Ghouzlani A; Lakhdar A; Rafii S; Karkouri M; Badou A Sci Rep; 2021 Nov; 11(1):21504. PubMed ID: 34728682 [TBL] [Abstract][Full Text] [Related]
38. A unique four-hub protein cluster associates to glioblastoma progression. Simeone P; Trerotola M; Urbanella A; Lattanzio R; Ciavardelli D; Di Giuseppe F; Eleuterio E; Sulpizio M; Eusebi V; Pession A; Piantelli M; Alberti S PLoS One; 2014; 9(7):e103030. PubMed ID: 25050814 [TBL] [Abstract][Full Text] [Related]
39. Adaptor Protein Complex 1 Sigma 3 Is Highly Expressed in Glioma and Could Enhance Its Progression. Ye T; Cheng Y; Li C Comput Math Methods Med; 2021; 2021():5086236. PubMed ID: 34367317 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas. Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]